Drug intelligence / Profile preview

Anberries

Development stage: Unknown
Lead developer: Eurospital
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Anberries is a brand of throat and voice care pastilles developed and marketed by Eurospital. Originally formulated in 1892 based on an ancient English recipe, these gummy pastilles are designed to soothe throat irritation, reduce inflammation, and support voice health. The product line includes several formulations, such as the classic Blackcurrant & Glycerin, as well as variants containing Red Currant & Echinacea, Honey & Propolis, Lime & Ginger, and Strawberry & Erisimo (hedge mustard). They are formulated without artificial colorings, preservatives, or gluten, and are commonly used to relieve minor throat discomfort and hoarseness.

Brand names: Anberries
Other names: Anberries Pastilles

Beyond the preview

Go deeper on Anberries.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anberries.